Catherine Johannes

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Filter by Publication Topic

Search Results

Clinical profile and treatment patterns in individuals with type 2 diabetes and chronic kidney disease who initiate a glp-1 receptor agonist: A multinational cohort study

Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study

FOUNTAIN: A modular research platform for integrated real-world evidence generation

Clinical outcomes in US patients initiating finerenone - a report from the FOUNTAIN platform

Risk of anaphylaxis among new users of GLP-1 receptor agonists: A cohort study

Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims

Abstracts of ICPE 2023, the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Canada, 25-27 August 2023 Abstracts: A modular research platform for integrated real-world evidence generation

Use of Janssen Ad26.COV2.S COVID-19 Vaccine (JCOVDEN) and mRNA COVID-19 vaccines in four large US national insurers

Use of very low-dose vaginal estrogens among postmenopausal women in the US

Abstracts of ICPE 2023, the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Canada, 25-27 August 2023 Abstracts

Abstracts of ICPE 2023, the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Canada, 25-27 August 2023 Abstracts

Characteristics of medication-initiator cohorts of patients with chronic kidney disease and type 2 diabetes in Japan: A report from fountain platform

Post-authorization safety studies of acute liver injury and severe complications of urinary tract infections in patients with type 2 diabetes exposed to dapagliflozin in a real-world setting

Post-authorization safety study of hospitalization for acute kidney injury in patients with type 2 diabetes exposed to dapagliflozin in a real-world setting

Adapting to the dynamic landscape of the COVID-19 pandemic: Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community, August 26-28, 2022, Copenhagen, Denmark

Capacity for identifying Janssen Ad26.COV2.S COVID-19 vaccination in four US health insurance and state Immunization Information System databases: preparation for a post authorization safety study

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database

Response to letter to the editor regarding "Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data"

Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data

Validity of claims-based algorithms to identify acute kidney injury, acute liver injury, severe complications of urinary tract infections, breast cancer, and bladder cancer among patients with type 2 diabetes: A pilot study